Colgate-Palmolive (India) Limited (NSE:COLPAL) announced its unaudited financial results for the first quarter ended 30 June 2026 on 29 July 2026. The company reported net sales of Rs 1,591 crore, representing a 12% year-on-year increase from Rs 1,421 crore in the corresponding quarter of the previous year. Net profit after tax stood at Rs 343 crore, up from Rs 321 crore in Q1 FY26.
Key Highlights
- Net sales for Q1 FY27 increased 12% year-on-year to Rs 1,591 crore from Rs 1,421 crore in Q1 FY26, driven by broad-based domestic growth across the portfolio.
- Net profit after tax rose to Rs 343 crore in Q1 FY27 compared to Rs 321 crore in Q1 FY26, representing growth of 7% on a reported basis and 11% excluding one-off and exceptional items.
- Gross margin expanded to 69.7% in Q1 FY27, an increase of 110 basis points year-on-year, supported by cost savings from Funding the Growth initiatives and strict financial discipline.
- The company introduced new products including Colgate MaxFresh Berry Blast toothpaste featuring blue cooling crystals and the Colgate Total Active Prevention Foaming Clean toothbrush to strengthen its premium portfolio.
- Earnings per share on a basic and diluted basis were Rs 12.61 for Q1 FY27, compared to Rs 11.79 for Q1 FY26, representing an increase of 7% year-on-year.
- Exceptional items totalling Rs 334 lakh in Q1 FY27 comprised severance and related expenses from organisational changes, compared to Rs 1,658 lakh in Q4 FY26.
- The statutory auditors conducted a limited review of the financial results as required under Regulation 33 of SEBI Listing Obligations and Disclosure Requirements Regulations 2015 and found no material misstatement.
About the Company
Colgate-Palmolive (India) Limited (NSE:COLPAL) is a leading FMCG company engaged primarily in the manufacture and distribution of oral care and personal care products. The company operates in India under the Personal Care segment, which includes oral care products such as toothpaste and toothbrushes. Colgate-Palmolive (India) is headquartered in Mumbai and operates research and manufacturing facilities including the Colgate Research Centre located at Hiranandani Gardens, Powai. The company is registered with CIN L24200MH1937PLCD027D0 and has paid-up equity share capital of Rs 27.20 crore, comprising shares of face value Rs 1 each. As of 30 June 2026, the company had no subsidiary, associate, or joint venture entities. The company's product portfolio spans premium and core segments, with continued focus on innovation and category premiumisation through new product launches and brand investments.
Announcement in Detail
Colgate-Palmolive (India) Limited's board of directors, meeting on 29 July 2026, approved and took on record the unaudited financial results for the first quarter ended 30 June 2026. The company reported total income of Rs 1,626.10 crore, comprising revenue from operations of Rs 1,606.30 crore (inclusive of Rs 12.74 crore in other operating income) and other income of Rs 22.80 crore. Net sales, excluding GST, totalled Rs 1,590.56 crore in Q1 FY27, representing growth of 12% compared to net sales of Rs 1,420.64 crore in Q1 FY26. This growth was characterised as broad-based across the domestic portfolio, with the toothpaste portfolio achieving high-single digit volume growth led by strong performance in the premium segment and sustained growth in the core portfolio.
Total expenses for Q1 FY27 amounted to Rs 1,160.57 crore, resulting in profit before exceptional items and tax of Rs 465.53 crore. After accounting for exceptional items of Rs 3.34 crore related to severance and organisational restructuring costs, profit before tax was Rs 462.19 crore. After tax expense of Rs 122.81 crore (current tax) and a deferred tax adjustment of Rs 3.70 crore, net profit for the quarter stood at Rs 343.08 crore. The gross margin, calculated from disclosed cost of materials consumed and purchases, reached 69.7%, up 110 basis points year-on-year. Management attributed this margin expansion to consistent cost savings realised from the Funding the Growth initiative and strict financial discipline, which were then reinvested in brand building and category premiumisation efforts through increased advertising spend of Rs 251.86 crore in Q1 FY27 compared to Rs 188.41 crore in Q1 FY26.
The company's earnings per share on a basic and diluted basis were Rs 12.61 for Q1 FY27, computed on the paid-up equity share capital of Rs 27.20 crore. The limited review report issued by the statutory auditors, SR BC & CO LLP, confirmed that based on their review conducted in accordance with Standard on Review Engagements 2410, nothing had come to their attention to suggest the statement contained any material misstatement or that required information had not been disclosed in accordance with Ind AS 34 and the SEBI Listing Regulations.
Impact on Investors
Investors will note that Colgate-Palmolive (India) Limited has delivered sequential growth in revenue and profitability during Q1 FY27. The disclosed net sales growth of 12% year-on-year, coupled with a 110 basis point expansion in gross margin to 69.7%, indicates the company has successfully balanced volume growth with cost management. Excluding exceptional items, net profit growth of 11% demonstrates underlying operational momentum. The significant increase in advertising expenditure year-on-year (Rs 251.86 crore in Q1 FY27 versus Rs 188.41 crore in Q1 FY26) reflects management's strategic decision to invest cash generated from margin expansion into brand building and premium segment development. Shareholders should observe that earnings per share of Rs 12.61 represents a 7% increase year-on-year, in line with reported net profit growth, with no dilution from share issuance or buyback activity during the quarter.
The filing shows that exceptional items in Q1 FY27 (Rs 334 lakh) relating to organisational restructuring were substantially lower than those recorded in Q4 FY26 (Rs 1,658 lakh), suggesting transition costs from prior-period restructuring are moderating. The company's capital structure remained unchanged, with paid-up equity share capital of Rs 27.20 crore and reserves (excluding revaluation reserve) of Rs 155.69 crore as of the full-year position. Investors should note that the company has identified only one reportable segment, Personal Care, implying revenue concentration in the oral care and allied categories without material diversification into other segments, which concentrates business performance on the company's core competency in this space.
Sector / Market Context
The Indian FMCG sector has continued to demonstrate growth momentum in calendar 2026 despite prevailing geopolitical uncertainties and commodity price volatility, as referenced in management commentary. Oral care remains a mature, high-penetration category within the Indian consumer staples market, with steady volume growth driven by premiumisation trends and rising consumer spending on quality personal care products. The company's emphasis on premium sub-segments, evidenced by the launch of new toothpaste variants with advanced formulations and expanded premium toothbrush offerings, aligns with sector-wide consumer migration toward higher-value products. Within the broader personal care market, innovation and brand investment remain key competitive drivers, as reflected in Colgate-Palmolive's increased advertising expenditure during the quarter. The company's focus on cost management through internal efficiency initiatives, while maintaining margin profile amid commodity price pressures, is consistent with competitive practices across FMCG manufacturers managing inflationary and currency-related headwinds during the period.